Screener
Krystal Biotech, Inc. KRYS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s net margin?
- Krystal Biotech, Inc. (KRYS) reported net margin of 53.9% in Q1 2026.
- How has Krystal Biotech, Inc.'s net margin changed year-over-year?
- Krystal Biotech, Inc.'s net margin increased by 45.1% year-over-year, from 37.2% to 53.9%.
- What is the long-term trend for Krystal Biotech, Inc.'s net margin?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s net margin has grown at a 56.2% compound annual growth rate (CAGR), from 21.6% to 52.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Krystal Biotech, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude